MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517073552 A) filed by Alcon Inc., Fribourg, Switzerland, on Aug. 1, for 'polymorphs of a jak1/tyk2 inhibitor and uses thereof.'
Inventor(s) include Anderholm, Heeren M. G.; Haxell, Thomas Francis Nelson; Mcclure, Michael S; Mciver, Andrew Louis; Cooley, Bob E.; Ellis, David Archer; and Delong, Mitchell A.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "Provided herein are solid forms, for example polymorphs, of 2 -(3 - ((7 R, 8a S) -7 -fl uo ro h exa hyd ro pyrro Io [ 1, 2-a ] pyra zi n - 2 (1 H) - yl) - 1- (5- methyl - 2 - ((I - methy l-lH-pyrazol-4-yl)amino)pyrimidin-4- yl)azetidin-3-yl)acetonitrile, which are useful for treating kinase- related diseases or disorders. The solid forms, and compositions thereof, are useful for treating diseases, including, without limitation, eye disease, such as glaucoma, ocular hypertension, ocular wound repair, neurodegenerative ocular diseases, retinal detachment, and non-ocular diseases such as neuronal damage, or skin wound repair, or inflammatory diseases, among others, in a subject."
The patent application was internationally filed on Jan. 04, 2024, under International application No.PCT/US2024/010347.
Disclaimer: Curated by HT Syndication.
